Lymphoma cell VEGFR2 expression detected by immunohistochemistry predicts poor overall survival in diffuse large B cell lymphoma treated with immunochemotherapy (R-CHOP)

Diffuse large B cell lymphoma (DLBCL) is clinically and biologically heterogeneous. In most cases of DLBCL, lymphoma cells coexpress vascular endothelial growth factor (VEGF) and its receptors VEGFR1 and VEGFR2, suggesting autocrine in addition to angiogenic effects. We enumerated microvessel densit...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Gratzinger, Dita, Advani, Ranjana, Zhao, Shuchun, Talreja, Neha, Tibshirani, Robert J., Shyam, Ragini, Horning, Sandra, Sehn, Laurie H., Farinha, Pedro, Briones, Javier, Lossos, Izidore S., Gascoyne, Randy D., Natkunam, Yasodha
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2009
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2809124/
https://ncbi.nlm.nih.gov/pubmed/19821819
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2141.2009.07942.x
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi